Genpact Limited (NYSE:G) announced a quarterly dividend on Monday, February 12th, Zacks reports. Stockholders of record on Friday, March 9th will be given a dividend of 0.075 per share by the business services provider on Wednesday, March 21st. This represents a $0.30 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date of this dividend is Thursday, March 8th. This is a positive change from Genpact’s previous quarterly dividend of $0.06.
Genpact has a dividend payout ratio of 16.3% indicating that its dividend is sufficiently covered by earnings. Analysts expect Genpact to earn $1.75 per share next year, which means the company should continue to be able to cover its $0.24 annual dividend with an expected future payout ratio of 13.7%.
Shares of Genpact stock opened at $32.23 on Thursday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.71 and a quick ratio of 1.71. The company has a market capitalization of $6,290.01, a price-to-earnings ratio of 24.05, a P/E/G ratio of 2.09 and a beta of 0.63. Genpact has a one year low of $23.34 and a one year high of $34.79.
In other Genpact news, insider Arvinder Singh sold 22,690 shares of the stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $33.95, for a total value of $770,325.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director James C. Madden sold 4,270 shares of the stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $30.92, for a total value of $132,028.40. The disclosure for this sale can be found here. Corporate insiders own 1.41% of the company’s stock.
A hedge fund recently raised its stake in Genpact stock. The Manufacturers Life Insurance Company lifted its position in shares of Genpact Limited (NYSE:G) by 7.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,508 shares of the business services provider’s stock after buying an additional 455 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 91.01% of the company’s stock.
Several analysts recently commented on the company. JPMorgan Chase & Co. decreased their price target on Genpact from $38.00 to $37.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 14th. BMO Capital Markets boosted their target price on Genpact to $35.00 and gave the stock a “market perform” rating in a research report on Tuesday, February 13th. Citigroup dropped their price objective on Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a report on Tuesday, February 13th. Cantor Fitzgerald reiterated a “buy” rating and issued a $36.00 price objective on shares of Genpact in a report on Tuesday, February 13th. Finally, Zacks Investment Research downgraded Genpact from a “hold” rating to a “sell” rating in a report on Thursday, February 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $34.65.
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.